Literature DB >> 7475956

Expression of constitutive endothelial nitric oxide synthase in human blood platelets.

K Sase1, T Michel.   

Abstract

Nitric oxide (NO) activates the soluble isoform of guanylate cyclase in platelets and inhibits platelet function. Several studies suggest the existence of a pathway for NO synthesis in platelets as a form of feedback inhibition, but the identity of the NO synthase (NOS) isoform present within platelets is unknown. We isolated human platelets, and synthesized cDNA from platelet RNA for analysis by PCR. Primers for human neuronal or inducible NOS failed to yield a PCR signal. However, primers specific for endothelial NOS (ecNOS) amplified a DNA band of the expected size. Analysis of nucleotide sequence revealed that the amplified DNA is ecNOS. NOS enzyme activity was detected in the platelet particulate subcellular fraction, as previously demonstrated for ecNOS in other cells. Thus, ecNOS is present in human platelets, and may play a role in the regulation of platelet function by an endogenous NO pathway.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7475956     DOI: 10.1016/0024-3205(95)02191-k

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  23 in total

Review 1.  Endothelial nitric oxide in humans in health and disease.

Authors:  P Vallance; A Hingorani
Journal:  Int J Exp Pathol       Date:  1999-12       Impact factor: 1.925

2.  Ultrastructural localisation of nitric oxide synthase, endothelin and binding sites of lectin (from Bandeirea simplicifolia) in the rat carotid artery after balloon catheter injury.

Authors:  A Loesch; P Milner; S C Anglin; R Crowe; S Miah; J R McEwan; G Burnstock
Journal:  J Anat       Date:  1997-01       Impact factor: 2.610

3.  Acetylcholine Inhibits Platelet Activation.

Authors:  John A Bennett; Sara K Ture; Rachel A Schmidt; Michael A Mastrangelo; Scott J Cameron; Lara E Terry; David I Yule; Craig N Morrell; Charles J Lowenstein
Journal:  J Pharmacol Exp Ther       Date:  2019-02-14       Impact factor: 4.030

4.  Abnormal platelet aggregation in idiopathic pulmonary arterial hypertension: role of nitric oxide.

Authors:  Metin Aytekin; Kulwant S Aulak; Sarah Haserodt; Ritu Chakravarti; Joseph Cody; Omar A Minai; Raed A Dweik
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-01-13       Impact factor: 5.464

5.  Nitric oxide released from activated platelets inhibits platelet recruitment.

Authors:  J E Freedman; J Loscalzo; M R Barnard; C Alpert; J F Keaney; A D Michelson
Journal:  J Clin Invest       Date:  1997-07-15       Impact factor: 14.808

Review 6.  Genetic risk factors and restenosis after percutaneous coronary interventions.

Authors:  A Kastrati; J Dirschinger; A Schömig
Journal:  Herz       Date:  2000-02       Impact factor: 1.443

Review 7.  Nitric oxide insufficiency and atherothrombosis.

Authors:  Barbara Voetsch; Richard C Jin; Joseph Loscalzo
Journal:  Histochem Cell Biol       Date:  2004-08-26       Impact factor: 4.304

8.  Polymorphisms of the eNOS gene are associated with disease activity in rheumatoid arthritis.

Authors:  Vera Bunjevacki; Nela Maksimovic; Biljana Jekic; Vera Milic; Ljiljana Lukovic; Ivana Novakovic; Nemanja Damjanov; Goran Radunovic; Tatjana Damnjanovic
Journal:  Rheumatol Int       Date:  2015-11-26       Impact factor: 2.631

9.  Circulating blood endothelial nitric oxide synthase contributes to the regulation of systemic blood pressure and nitrite homeostasis.

Authors:  Katherine C Wood; Miriam M Cortese-Krott; Jason C Kovacic; Audrey Noguchi; Virginia B Liu; Xunde Wang; Nalini Raghavachari; Manfred Boehm; Gregory J Kato; Malte Kelm; Mark T Gladwin
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-05-23       Impact factor: 8.311

10.  Neuronal nitric oxide synthase contributes to the regulation of hematopoiesis.

Authors:  Peter Krasnov; Tatyana Michurina; Michael A Packer; Yuri Stasiv; Naoki Nakaya; Kateri A Moore; Kenneth E Drazan; Grigori Enikolopov
Journal:  Mol Med       Date:  2008 Mar-Apr       Impact factor: 6.354

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.